Neuralink’s ‘breakthrough device’ clearance from FDA does not mean they have cured blindness

from TechCrunch Startup News · host TechCrunch

Neuralink, the Elon Musk-owned brain-computer interface company, has received “breakthrough device” clearance from the FDA. But this does not mean they have developed a cure for blindness, whatever Musk might say. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Sep 19, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Neuralink’s ‘breakthrough device’ clearance from FDA does not mean they have cured blindness

0:00 4:46

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TechCrunch Startup News?

This episode is 4 minutes long.

When was this TechCrunch Startup News episode published?

This episode was published on September 19, 2024.

Can I download this TechCrunch Startup News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!